MedPath

Health Canada Approvals

Health Canada approved pharmaceutical products and drug approvals in Canada

Health Canada
Canada
594 Approvals
Showing 1 to 20 of 594 approvalsPage 1 of 30

PRZ-OLMESARTAN/HCTZ

Approved: Oct 4, 2022
pharmaris canada inc

PRZ-OLMESARTAN/HCTZ

Approved: Oct 4, 2022
pharmaris canada inc

PRZ-OLMESARTAN/HCTZ

Approved: Oct 4, 2022
pharmaris canada inc

NIGHTTIME SLEEP AID

Approved: Jun 17, 2022
the shandex sales group limited

CHILDREN'S TYLENOL EASY DISSOLVE

Approved: May 7, 2022
kenvue canada inc.

PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Approved: Jan 6, 2022
fresenius kabi canada ltd

ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN

Approved: Jan 17, 2022
kenvue canada inc.

GLICLAZIDE MR

Approved: Jul 8, 2022
sanis health inc

LISINOPRIL (TYPE Z)

Approved: Apr 12, 2022
sanis health inc

LISINOPRIL (TYPE Z)

Approved: Apr 12, 2022
sanis health inc

LISINOPRIL (TYPE Z)

Approved: Apr 12, 2022
sanis health inc

M-VALSARTAN

Approved: Jul 28, 2022
mantra pharma inc

CC+ NUDE GLOW

Approved: Mar 21, 2022
it cosmetics canada

MINT-QUETIAPINE XR

Approved: Apr 7, 2022
mint pharmaceuticals inc

MINT-QUETIAPINE XR

Approved: Oct 4, 2022
mint pharmaceuticals inc

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.